---
title: "Boai NKY Medical Holdings Ltd. (300109.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300109.SZ.md"
symbol: "300109.SZ"
name: "Boai NKY Medical Holdings Ltd."
industry: "Commodity Chemicals"
datetime: "2026-06-27T14:24:04.096Z"
locales:
  - [en](https://longbridge.com/en/quote/300109.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300109.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300109.SZ.md)
---

# Boai NKY Medical Holdings Ltd. (300109.SZ)

## Company Overview

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, agriculture, stationery, semiconductor, and other industries.

| Item | Detail |
|------|--------|
| Industry | Commodity Chemicals |
| Exchange | CN Market |
| Website | [www.boai-nky.com](https://www.boai-nky.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-27T04:30:11.000Z

**Overall: C (0.52)**

**Industry**: Commodity Chemicals

| Metric | Value |
|--------|-------|
| Industry Ranking | 141 / 276 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -22.21% |  |
| Net Profit YoY | -43.50% |  |
| P/B Ratio | 2.38 |  |
| Dividend Ratio | 2.43% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 8826554040.52 |  |
| Revenue | 1195361690.81 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.70% | C |
| Profit Margin | 14.59% | A |
| Gross Margin | 43.52% | B |
| Revenue YoY | -22.21% | E |
| Net Profit YoY | -43.50% | D |
| Total Assets YoY | -3.72% | D |
| Net Assets YoY | -0.39% | D |
| Cash Flow Margin | 207.68% | B |
| OCF YoY | -22.21% | E |
| Turnover | 0.27 | D |
| Gearing Ratio | 15.20% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Boai NKY Medical Holdings Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-22.21%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-43.50%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.38",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.43%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "8826554040.52",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1195361690.81",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.70%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "14.59%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "43.52%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-22.21%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-43.50%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-3.72%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.39%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "207.68%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-22.21%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.27",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "15.20%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 50.60 | 113/276 | 40.06 | 35.22 | 30.22 |
| PB | 2.38 | 125/276 | 2.46 | 2.30 | 2.20 |
| PS (TTM) | 7.38 | 231/276 | 6.63 | 5.92 | 5.56 |
| Dividend Yield | 2.43% | 22/276 | 1.48% | 1.41% | 1.32% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Grace (603256.SH) | A | A | C | B | B | B |
| 02 | SINOMATECH (002080.SZ) | B | B | C | D | B | B |
| 03 | ZJJH (600160.SH) | B | B | B | B | B | B |
| 04 | TINCI (002709.SZ) | B | A | B | B | B | B |
| 05 | Yoke Technology (002409.SZ) | B | B | C | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300109.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300109.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300109.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300109.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**